Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jul;25(3):281-4.
doi: 10.1016/j.sjopt.2011.04.010. Epub 2011 Apr 30.

Outcomes with the Boston Type 1 Keratoprosthesis at Instituto de Microcirugía Ocular IMO

Jose L Güell  1 , Edilio Arcos, Oscar Gris, Diego Aristizabal, Miguel Pacheco, Claudia L Sanchez, Felicidad Manero
Affiliations

Outcomes with the Boston Type 1 Keratoprosthesis at Instituto de Microcirugía Ocular IMO

Jose L Güell et al. Saudi J Ophthalmol. 2011 Jul.

Abstract

Purpose: To report the outcomes on the Boston Type 1 Keratoprosthesis at our institution.

Design: Retrospective analysis case series.

Participants: We analyzed 54 eyes of 53 patients who previously underwent Boston Type 1 Keratoprosthesis surgery at our institution from July 2006 to March 2011.

Methods: Preoperative and postoperative parameters were collected and analyzed.

Main outcome measures: Visual acuity and keratoprosthesis stability.

Results: Common preoperative diagnoses were penetrating keratoplasty failure in 49 eyes (90.7%), chronic keratitis in 2 eyes (3.7%), ocular cicatricial pemphigoid in 1 eye (1.85%), Stevens Johnson syndrome in 1 eye (1.85%) and corneal vascularization in 1 eye (1.85%). Additionally, 40 eyes (74%) had preoperative glaucoma, and an Ahmed valve was implanted in 55% of them. Preoperative BCVA ranged from 20/200 to light perception. At an average follow-up of 20.15 months ± 12.7 (range, 1-56), postoperative vision improved to ⩾20/200 in 18 eyes (33.3%) and ⩾20/50 in 4 eyes (7.4%). The graft retention was 96%.

Conclusions: The Boston Type 1 keratoprosthesis is a valid option for high-risk patients. The design improvements in the Boston keratoprosthesis, as well as the daily implementation of the therapeutic methods, have notably diminished occurrence of the most serious complications, such as corneal necrosis and endophthalmitis. As such, glaucoma and its subsequent complications now stand as the most prevalent prognostic factor in the long term.

Keywords: Boston Type 1 Keratoprosthesis; Corneal necrosis; Instituto de Microcirugía Ocular IMO; Ocular cicatricial pemphigoid; Stevens Johnson syndrome; Visual acuity.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The arrow shows initial necrosis: FP = Front Part, C = Cornea, BP = Back Plate.
Figure 2
Figure 2
Stevens Johnson syndrome–preoperative.
Figure 3
Figure 3
The same patient, 17 months after surgery.
See this image and copyright information in PMC

References

    1. Aldave A.J., Kamal K.M., Vo R.C., Yu F. The Boston type I keratoprosthesis: improving outcomes and expanding indications. Ophthalmology. 2009;116:640–651. - PubMed
    1. Barber J.C. Keratoprosthesis: past and present. Int. Ophthalmol. Clin. 1988;28(2):1039. - PubMed
    1. Bersudsky V., Blum-Hareuveni T., Rehany U., Rumelt S. The profile of repeated corneal transplantation. Ophthalmology. 2001;108(3):461–469. - PubMed
    1. Chew H.F., Ayres B.D., Hammersmith K.M. Boston keratoprosthesis outcomes and complications. Cornea. 2009;28:989–996. - PubMed
    1. Dandona L., Naduvilath T.J., Janarthanan M., Ragu K., Rao G.N. Survival analysis and visual outcome in a large series of corneal transplants in India. Br. J. Ophthalmol. 1997;81(9):726–731. - PMC - PubMed